Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replicon system for Lassa virus.

Meike Hass1, Uta Gölnitz, Stefanie Müller

  • 1Department of Virology, Bernhard-Nocht-Institute of Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359 Hamburg, Germany.

Journal of Virology
|November 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipah Virus Shedding in Urine from Fruit Bats, Sri Lanka, 2018-2019.

Emerging infectious diseases·2026
Same author

Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease.

The Journal of infectious diseases·2026
Same author

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial.

Nature medicine·2026
Same author

Genomic Surveillance of Lassa Virus through In-Country Sequencing, Guinea.

Emerging infectious diseases·2026
Same author

Delayed type I interferon response and the subsequent out-of-sequence cytokine signal inhibit T cell induction in non-surviving Ebola virus-infected patients.

Frontiers in immunology·2026
Same author

Non-Mastomys rodents harbour ancient Lassa virus lineages within Benin and Nigeria's Guinea savanna belt.

Scientific reports·2026

Researchers developed a novel Lassa virus replicon system for functional analysis. This tool enables studying Lassa virus replication and testing antivirals safely outside high-containment labs.

Area of Science:

  • Virology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Lassa virus causes hemorrhagic fever and is endemic to West Africa.
  • Functional analysis of highly pathogenic viruses like Lassa virus requires specialized containment.
  • A need exists for safer methods to study Lassa virus replication and develop therapeutics.

Purpose of the Study:

  • To develop and characterize a novel Lassa virus replicon system.
  • To enable functional analysis of Lassa virus replication and transcription.
  • To facilitate antiviral drug screening outside of Biosafety Level 4 laboratories.

Main Methods:

  • Construction of genomic and antigenomic minigenomes (MGs) containing Lassa virus S RNA elements and a Renilla luciferase reporter gene.
  • Expression of Lassa virus proteins (NP, L, Z) using T7 promoter-driven plasmids.

Related Experiment Videos

  • Transfection of BSR T7/5 cells (stably expressing T7 RNA polymerase) with MGs and expression plasmids.
  • Optimization of construct ratios and MG 5' end modifications.
  • Northern blot analysis to confirm MG replication and transcription.

    • Main Results:

    • High levels of reporter gene expression were achieved, indicating successful replication and transcription.
    • Optimized system demonstrated maximum activity 24-36 hours post-transfection with a high signal-to-noise ratio.
    • Lassa virus Z protein was found to downregulate replicon activity.
    • Ribavirin and alpha interferon inhibited replicon activity, suggesting interference with viral RNA synthesis or assembly.

    Conclusions:

    • The study successfully established the first replicon system for a highly pathogenic arenavirus, Lassa virus.
    • This system serves as a valuable tool for investigating Lassa virus replication and transcription mechanisms.
    • The developed replicon system facilitates antiviral testing under reduced biosafety conditions.